Vitrolife AB

VITR · Nasdaq Stockholm · Healthcare

91.80SEK −1.1%last day

Price as of 2 October 2026

The price over the past year, with dividends: −28.5%

Performance

1 month

−4.8%

1 year

−28.5%

3 years, per year

−12.6%

5 years, per year

−27.2%

Largest fall, 3 years

−77.5%

Below the peak now

−83.3%

Volatility, 1 year

41.1%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

1.5

Dividend yield

1.2%

Return on equity

−61.3%

Net margin

−147.0%

Market value

1.2 bn USD

Quality, value and trend

Where Vitrolife stands against every Nordic stock today. 100 is best.

Quality55

Profitability and a sound balance sheet over time. Better than 55% of Nordic stocks.

Value23

The price measured against earnings, assets and cash flow. Better than 23% of Nordic stocks.

Trend41

The price development over the past year. Better than 41% of Nordic stocks.

Combined28

Quality, value and trend together. Better than 28% of Nordic stocks.

About Vitrolife

Vitrolife AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 1,100 employees.

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis